(Q36805878)
Statements
Melphalan, lenalidomide and dexamethasone for the treatment of immunoglobulin light chain amyloidosis: results of a phase II trial (English)
Jaymin M Patel
Anthony C Shelton
Jerome B Zeldis
David C Seldin
9 November 2012
1 reference